A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 218
Summary
- Conditions
- Pancreatic Cancer
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Description
Immunohistochemistry and gene test for hENT1, DCK, SMAD4, CES2, BRCA 1/2,PALB2, MMRd, MSI, Tumor Ag and etc. on Cancer sample Collect data of Biomarker for pancreatic cancer Compare with Big data and Cohort study in National cancer center The number of subjects is changed by statistical consideratio...
Immunohistochemistry and gene test for hENT1, DCK, SMAD4, CES2, BRCA 1/2,PALB2, MMRd, MSI, Tumor Ag and etc. on Cancer sample Collect data of Biomarker for pancreatic cancer Compare with Big data and Cohort study in National cancer center The number of subjects is changed by statistical consideration. 218->238
Tracking Information
- NCT #
- NCT04281511
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Sangmyung Woo National Cancer Center
Get Well Soon